COMPANY NEWS IN BRIEF

WhatsApp urged to stop sharing dataFacebook’s messaging service WhatsApp was given a one-month ultimatum by one of Europe’s strictest privacy watchdogs, which ordered it to stop sharing user data with its parent without getting the necessary consent.France’s data protection authority CNIL gave a sharp warning to WhatsApp by issuing a formal notice, criticising it for “insufficiently” cooperating.The decision comes a year after European Union privacy authorities said they had “serious concerns” about the sharing of WhatsApp user data for purposes that weren’t included in the terms of service and privacy policy when people signed up to the service.FIN24Trump security plan boosts case for steel, aluminium curbsUS President Donald Trump's new security strategy bolsters the case for trade actions to protect US economic interests on national security grounds, including possible import tariffs on steel and aluminium, a senior Trump administration official said on Tuesday.The strategy document released on Monday did not specifically mention the Commerce Department's "Section 232" investigations into whether rising steel and aluminium imports represent a threat to national security. With recommendations due in January, the probes could lead to broad tariffs or import quotas under a Cold War-era trade law.NAMPA/REUTERSFedEx quarterly profit rises on strong package volumePackage delivery company FedEx Corp on Tuesday reported a better-than-expected quarterly net profit due to strong global demand and increased volumes during the peak holiday shipping season, but said its results were hit by lingering effects from a June cyber-attack on its Dutch TNT Express unit.The Memphis-based company, often considered a bellwether for the U.S. economy, as is its rival United Parcel Service Inc , said the cyber-attack cut US$0.31 per diluted share from its fiscal second-quarter profit.NAMPA/REUTERSPfizer, Exelixis cancer drugs get FDA approval for wider useCancer treatments from Pfizer Inc and Exelixis Inc on Tuesday won approval from the US Food and Drug Administration for expanded use in previously untreated patients.Pfizer's Bosulif was expanded to treat newly-diagnosed adult patients with a rare, chronic form of blood cancer. The drug was first approved in 2012 to treat patients with resistance or intolerance to prior therapy for the cancer. The US regulator expanded the label of Exelixis's drug, Cabometyx, to treat patients with the most common form of kidney cancer.NAMPA/REUTERSMay, Trump agree on need for quick post-Brexit trade dealBritish Prime Minister Theresa May and US President Donald Trump "agreed on the importance of a swift post-Brexit bilateral trade deal" during talks Tuesday, her Downing Street office said.The leaders discussed a future trade deal between the two countries during a phone call which focused on several other issues including Jerusalem, a spokesman said.It was their first conversation since a rare public row erupted last month after May criticised Trump's retweeting of a fringe British far-right leader's anti-Muslim messages, which provoked an angry response from the president.NAMPA/AFPFitch still sees political uncertainty in SARatings agency Fitch says political uncertainty will persist in South Africa following the election of Cyril Ramaphosa as leader of the ruling African National Congress.In a statement on Thursday, Fitch said the closeness of Ramaphosa's victory against Nkosazana Dlamini-Zuma, and the likely challenges in agreeing and implementing changes to existing economic and fiscal settings suggest that the policy paralysis prior to the governing party's 16-20 December 54th National Conference may not be quickly resolved.NAMPA/ANA

COMPANY NEWS IN BRIEF

Kommentaar

Republikein 2025-11-06

Meld asseblief aan om kommentaar te lewer

COMPANY NEWS IN BRIEF

Kommentaar

Republikein 2025-11-06

Meld asseblief aan om kommentaar te lewer

Intekening vereis om toegang tot inhoud te kry. ×

MELD AAN

Advertensie

Intekening vereis om toegang tot inhoud te kry.